eNauka - pregled
Pregled prema Autor Pour, Ludek
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2018 | Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma | Mateos, María-Victoria; Dimopoulos, Meletios A.; Cavo, Michele; Suzuki, Kenshi; Jakubowiak, Andrzej; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Kaplan, Polina;
Pour, Ludek; Cook, Mark; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna M.; Campbell, Philip; Shelekhova, Tatiana; Yoon, Sung-Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Chiu, Christopher; Wang, Jianping; Carson, Robin; Crist, Wendy; Deraedt, William; Nguyen, Huong; Qi, Ming; San-Miguel, Jesus;
| Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2024 | Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study![]() | Pour, Ludek; ...; Bila, Jelena S. | Научни чланак | 21aM21a - Водећи међународни часопис категорије M21a |
| 2023 | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy![]() | Mateos, Maria-Victoria; Szarejko, Monika; Bila, Jelena S.
Thuresson, Marcus; Norin, Stefan; Jarefors, Sara; Richardson, Paul; Pour, Ludek;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
